CONMED Corp. (CNMD) Altrus Thermal Tissue Fusion System Given Marketing Clearance by FDA
Tweet Send to a FriendGet Alerts CNMD Hot Sheet
Up)
Trade CNMD Now!
CONMED Corporation (NASDAQ: CNMD) announced that their Altrus Thermal Tissue Fusion System has been granted marketing clearance from the U.S. Food and Drug Administration.
The company believes that the current marketplace for energy based instruments approximates $1.5 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
The company believes that the current marketplace for energy based instruments approximates $1.5 billion.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Conmed Corp (CNMD) Declares $0.15 Quarterly Dividend; 1.8% Yield
- Merck (MRK) Says Efficacy Not Achieved in Preladenant Phase 3s; Will Discontinue
- Sprint (S), SoftBank Receive Final State Regulatory Approval in Proposed Deal
Create E-mail Alert Related Categories
Corporate News, FDA
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
